SCHEMBL2780201

SCHEMBL2780201

FC(F)(F)C(F)(F)CCCCI.OCCCCC(F)(F)C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2636314 0.88
SCHEMBL864384 0.88 SMN1; SMN2 (0.32)
SCHEMBL8671685 0.85 LMNA (0.35)
SCHEMBL2780203 0.85
SCHEMBL2637189 0.85 LMNA (0.35)
SCHEMBL6852245 0.85 LMNA (0.35)
SCHEMBL879892 0.85 LMNA (0.35)
SCHEMBL6849263 0.85 LMNA (0.35)
SCHEMBL338407 0.85 SMN1; SMN2 (0.33)
SCHEMBL6650821 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2258375-A1 17B-alkyl-17alpha-oxy-estratrienes Bayer Schering Pharma Aktiengesellschaft (DE) 2010-12-08 EP disclosed